CSIMarket
 
Concord Medical Services Holdings Ltd  (CCM)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $0.6069 $0.20 47.664%
Day's High: $0.74 Week Perf: 51.69 %
Day's Low: $ 0.40 30 Day Perf: 32.63 %
Volume (M): 195 52 Wk High: $ 1.60
Volume (M$): $ 118 52 Wk Avg: $1.14
Open: $0.41 52 Wk Low: $0.38



 Market Capitalization (Millions $) 80
 Shares Outstanding (Millions) 131
 Employees -
 Revenues (TTM) (Millions $) 68
 Net Income (TTM) (Millions $) -111
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 32

Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd is a Chinese company that provides radiotherapy diagnostic and treatment equipment and services. It operates a network of radiation oncology centers in China, offering advanced treatment options for cancer patients. The company also provides management services to other medical institutions. Concord Medical Services Holdings Ltd aims to improve cancer treatment in China by leveraging advanced technologies and expertise from around the world.


   Company Address: Room 2701-05, Tower A, Global Trade Center Beijing 100013
   Company Phone Number: 10) 5903 6688   Stock Exchange / Ticker: NYSE CCM
   CCM is expected to report next financial results on April 18, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cardiff Lexington Corporation

Cardiff Lexington Corporation Demonstrates Resilience Despite Tough Financial Period

Cardiff Lexington Corporation, despite facing a tough financial interval closing on December 31, 2023, has managed to achieve significant improvements and display resilience in the face of adversity. While CDIF's gain per share remained at $0.00, it is important to note that this is a significant leap from the previous year's loss of $-0.01 per share.
Furthermore, CDIF's revenue experienced a considerable decline of -19.263% to $2.07 million from $2.57 million in the same reporting period a year ago. However, it is important to highlight that this dip was also seen across the entire Healthcare Facilities sector, making CDIF's performance in line with industry trends. Additionally, there was a sequential decrease of -39.748% from $3.44 million, indicating some challenges faced during the reporting period.

Lifemd Inc

Healthcare Facilities company sees surge in revenue and reduction in deficit during recent fiscal period

Lifemd Inc, a renowned provider of virtual primary care services, has shown impressive growth in its most recent fiscal period. The company reported an energetic revenue rise of 64.276% to $45.50 million, which helped reduce losses to $-0.11 per share compared to $-0.36 per share in the corresponding reporting period a year ago. This significant improvement is a positive sign for investors and indicates that Lifemd Inc is on track to achieve profitability.
In contrast to the previous quarter, where revenue improved by 20.279% from $37.83 million, Lifemd Inc's income per share also witnessed improvement, increasing from $-0.20 per share. These positive developments highlight the company's strong performance and efficient cost management strategies.

Enhabit Inc

Enhabit Inc Reports $-0.13 per Share Deficit in Fiscal Fourth Quarter of 2023

Enhabit Inc, a home health and hospice care provider, has recently reported its financial results for the fiscal period ending in December 2023. The company recorded a loss of $-0.13 per share, compared to a loss of $-0.05 per share in the preceding reporting period. This represents a decrease in earnings from the same reporting period a year ago, where the company reported a loss of $-1.39 per share.
Despite the decrease in earnings per share, Enhabit Inc saw a slight increase in revenue of 0.89% from the previous reporting period, totaling $258.30 million. The company also reported a significant decrease in net deficit from $-68.000 million in the same reporting period a year ago to $-5.900 million in the current period.

Viemed Healthcare Inc

Viemed Healthcare Inc. Stuns Market with Impressive Earnings and Bold Strategic Move

Viemed Healthcare Inc's impressive earnings report and strategic decision to delist from the TSX in order to focus on growth on the NASDAQ Capital Market are certainly noteworthy developments in the stock market. The company's revenue and profit per share significantly outperformed its industry peers in the most recent fiscal period, indicating strong business performance and growth potential.
One key highlight from Viemed Healthcare's financial results is the significant increase in revenue and profit per share, showcasing the company's ability to drive top-line growth and improve profitability. Additionally, the company's improving profit margins and operating earnings demonstrate its operational efficiency and strategic management.

Progyny Inc

Serious headline: Progyny Inc. Reports Extraordinary Financial Performance in Q4 2023

Progyny Inc. has recently made headlines in the stock market with its impressive financial performance in the fourth quarter of 2023, showcasing substantial growth in both income per share and revenue. The company reported a significant increase in income per share by 339.82% year on year, soaring to $0.13 per share, and a revenue growth of 26.045% to $270.14 million. These numbers indicate a positive trajectory for the company, marking a notable improvement from the preceding period.
Furthermore, Progyny Inc. also reported a remarkable increase in net profits in the fourth quarter of 2023 earnings season, showing a staggering 295.25% growth from the same period a year ago. The company emphasized its improving profit margins, with net margin rising to 4.99% and operating margin edging up to 5.11%. Operating earnings also saw a substantial rise of 317.42% to $13.8 million.






 

Concord Medical Services Holdings Ltd's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com